Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Carcinoma, Non-Small-Cell Lung 11Gliosarcoma 8Prostatic Neoplasms 7Glioblastoma 7Squamous Cell Carcinoma of Head and Neck 5Lung Neoplasms 5Breast Neoplasms 4Brain Neoplasms 4Sarcoma 3Astrocytoma 3Wilms Tumor 2Malignant mesenchymal tumor 2Liposarcoma 2Leiomyosarcoma 2Histiocytoma, Malignant Fibrous 2Hemangiosarcoma 2Head and Neck Neoplasms 2Fibrosarcoma 2Central Nervous System Neoplasms 2Adenocarcinoma, Bronchiolo-Alveolar 2Adenocarcinoma of Lung 2Vulvar Neoplasms 1Vomiting 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Stomach Neoplasms 1Stage II Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 1Sarcoma, Synovial 1Sarcoma, Alveolar Soft Part 1Rhabdoid Tumor 1

Interventions

Standard of Care 2Curcumin 2eucerin 1dimethicone 1cetyl alcohol, propylene glycol, sodium lauryl sulfate non-lipid cleansing lotion 1Zinc Oxide 1Triamcinolone Acetonide 1Sodium Hypochlorite 1Radiotherapy, Conformal 1Practice Guidelines as Topic 1Petrolatum 1Gels 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Radiodermatitis × Radiotherapy, Conformal × Clear all
NCT02142959 2025-06-03

RTA 408 Lotion in Patients at Risk for Radiation Dermatitis - PRIMROSE

Biogen

Phase 2 Completed
187 enrolled 11 charts
Breast

Breast Neoplasms, Inflammation, Radiodermatitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡